Search Results - "Evans, Brad P."

Process development of a FGF21 protein–antibody conjugate by Dirksen, Anouk, Davis, Keith A., Collins, Joe T., Bhattacharya, Keshab, Finneman, Jari I., Pepin, Erin L., Ryczek, Jeffrey S., Brown, Paul W., Wellborn, William B., Mangalathillam, Ratish, Evans, Brad P., Pozzo, Mark J., Finn, Rory F.

“…A scalable, viable process was developed for the Fibroblast Growth Factor 21 (FGF21) protein‐antibody conjugate, CVX‐343, an extended half‐life therapeutic for…”
Get full text

Examination of edge effects with different storage conditions of preplated dimethyl sulfoxide nanospots in ChemLib 1,536- and 3,456-well assay-ready plates by Turner, Benjamin A, Evans, Brad P, Pearson, Tania T, Braden, Timothy K, Wise, Scott C

“…For ultra-high-throughput screening, 10-30 nl of compound dissolved in 75% dimethyl sulfoxide (DMSO)/25% water (vol/vol) is spotted into 1,536- and 3,456-well…”
Get more information

P rocess development of a FGF21 protein–antibody conjugate by Dirksen, Anouk, Davis, Keith A., Collins, Joe T., Bhattacharya, Keshab, Finneman, Jari I., Pepin, Erin L., Ryczek, Jeffrey S., Brown, Paul W., Wellborn, William B., Mangalathillam, Ratish, Evans, Brad P., Pozzo, Mark J., Finn, Rory F.

“…A scalable, viable process was developed for the Fibroblast Growth Factor 21 (FGF21) protein‐antibody conjugate, CVX‐343, an extended half‐life therapeutic for…”
Get full text